4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen

C111H122ClF3N30O11 — CID 159350288

IUPAC4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen
SMILESCOC(=O)c1ccc(Oc2cnc(N)c(-c3nc4ccc(C)cc4[nH]3)n2)cc1.Cc1ccc2nc(-c3nc(Oc4c(F)cccc4F)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(C(=O)O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(F)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccccc4Cl)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C20H17N5O3.C19H15N5O3.C18H14ClN5O.C18H13F2N5O.C18H14FN5O.C18H15N5O2.17H2/c1-11-3-8-14-15(9-11)24-19(23-14)17-18(21)22-10-16(25-17)28-13-6-4-12(5-7-13)20(26)27-2;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)27-12-5-3-11(4-6-12)19(25)26;1-10-6-7-12-13(8-10)23-18(22-12)16-17(20)21-9-15(24-16)25-14-5-3-2-4-11(14)19;1-9-5-6-12-13(7-9)24-18(23-12)15-17(21)22-8-14(25-15)26-16-10(19)3-2-4-11(16)20;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)25-12-5-3-11(19)4-6-12;1-10-2-7-13-14(8-10)22-18(21-13)16-17(19)20-9-15(23-16)25-12-5-3-11(24)4-6-12;;;;;;;;;;;;;;;;;/h3-10H,1-2H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23)(H,25,26);2-9H,1H3,(H2,20,21)(H,22,23);2-8H,1H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23);2-9,24H,1H3,(H2,19,20)(H,21,22);17*1H
InChIKeyLHFVFKYKVQYZOT-UHFFFAOYSA-N
MW2144.84 g/mol
LogP26.66
Rot. Bonds20

About 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen

4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen (PubChem CID 159350288) has the molecular formula C111H122ClF3N30O11 and a molecular weight of 2144.84 g/mol. Its IUPAC name is 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen.

Molecular Properties

Compound Name4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen
PubChem CID159350288
Molecular FormulaC111H122ClF3N30O11
Molecular Weight2144.84 g/mol
Exact Mass2142.95
IUPAC Name4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen
SMILESCOC(=O)c1ccc(Oc2cnc(N)c(-c3nc4ccc(C)cc4[nH]3)n2)cc1.Cc1ccc2nc(-c3nc(Oc4c(F)cccc4F)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(C(=O)O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(F)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccccc4Cl)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H]
InChIInChI=1S/C20H17N5O3.C19H15N5O3.C18H14ClN5O.C18H13F2N5O.C18H14FN5O.C18H15N5O2.17H2/c1-11-3-8-14-15(9-11)24-19(23-14)17-18(21)22-10-16(25-17)28-13-6-4-12(5-7-13)20(26)27-2;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)27-12-5-3-11(4-6-12)19(25)26;1-10-6-7-12-13(8-10)23-18(22-12)16-17(20)21-9-15(24-16)25-14-5-3-2-4-11(14)19;1-9-5-6-12-13(7-9)24-18(23-12)15-17(21)22-8-14(25-15)26-16-10(19)3-2-4-11(16)20;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)25-12-5-3-11(19)4-6-12;1-10-2-7-13-14(8-10)22-18(21-13)16-17(19)20-9-15(23-16)25-12-5-3-11(24)4-6-12;;;;;;;;;;;;;;;;;/h3-10H,1-2H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23)(H,25,26);2-9H,1H3,(H2,20,21)(H,22,23);2-8H,1H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23);2-9,24H,1H3,(H2,19,20)(H,21,22);17*1H
InChIKeyLHFVFKYKVQYZOT-UHFFFAOYSA-N
XLogP26.66
TPSA622.09 Ų
H-Bond Donors14
H-Bond Acceptors34
Rotatable Bonds20
Heavy Atoms156
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002144.84
LogP ≤ 526.66
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1034

Analyze 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen?
The IUPAC name of 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen (CID 159350288) is 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen.
What is the SMILES notation for 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen?
The canonical SMILES for 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen is COC(=O)c1ccc(Oc2cnc(N)c(-c3nc4ccc(C)cc4[nH]3)n2)cc1.Cc1ccc2nc(-c3nc(Oc4c(F)cccc4F)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(C(=O)O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(F)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccc(O)cc4)cnc3N)[nH]c2c1.Cc1ccc2nc(-c3nc(Oc4ccccc4Cl)cnc3N)[nH]c2c1.[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].[H][H].
What is the InChIKey of 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen?
The InChIKey is LHFVFKYKVQYZOT-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H17N5O3.C19H15N5O3.C18H14ClN5O.C18H13F2N5O.C18H14FN5O.C18H15N5O2.17H2/c1-11-3-8-14-15(9-11)24-19(23-14)17-18(21)22-10-16(25-17)28-13-6-4-12(5-7-13)20(26)27-2;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)27-12-5-3-11(4-6-12)19(25)26;1-10-6-7-12-13(8-10)23-18(22-12)16-17(20)21-9-15(24-16)25-14-5-3-2-4-11(14)19;1-9-5-6-12-13(7-9)24-18(23-12)15-17(21)22-8-14(25-15)26-16-10(19)3-2-4-11(16)20;1-10-2-7-13-14(8-10)23-18(22-13)16-17(20)21-9-15(24-16)25-12-5-3-11(19)4-6-12;1-10-2-7-13-14(8-10)22-18(21-13)16-17(19)20-9-15(23-16)25-12-5-3-11(24)4-6-12;;;;;;;;;;;;;;;;;/h3-10H,1-2H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23)(H,25,26);2-9H,1H3,(H2,20,21)(H,22,23);2-8H,1H3,(H2,21,22)(H,23,24);2-9H,1H3,(H2,20,21)(H,22,23);2-9,24H,1H3,(H2,19,20)(H,21,22);17*1H.
What are the key properties of 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen?
4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen has a molecular weight of 2144.84 g/mol, XLogP of 26.66, 20 rotatable bonds, 14 hydrogen bond donors, and 34 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoic acid;4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxyphenol;5-(2-chlorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(2,6-difluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;5-(4-fluorophenoxy)-3-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-amine;methyl 4-[5-amino-6-(6-methyl-1H-benzimidazol-2-yl)pyrazin-2-yl]oxybenzoate;molecular hydrogen is sourced from PubChem (CID 159350288), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).